Exelixis Inc (EXEL)
33.81
-0.22
(-0.65%)
USD |
NASDAQ |
Dec 27, 16:00
33.72
-0.09
(-0.27%)
After-Hours: 20:00
Exelixis Revenue (Annual): 1.830B for Dec. 31, 2023
Revenue (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Revenue (Annual) Benchmarks
Merck & Co Inc | 60.12B |
ADMA Biologics Inc | 258.22M |
Alnylam Pharmaceuticals Inc | 1.828B |
Incyte Corp | 3.696B |
Sarepta Therapeutics Inc | 1.243B |